PREPARATIONS CONTAINING A FLUOROCARBON EMULSION AND USABLE AS COSMETICS OR DERMATICS

Abstract: The invention relates to preparations for the improved release of oxygen into the skin and to the use of same as cosmetics/dermatics. The preparations according to this invention contain, as the essential component, fluorocarbon emulsions consisting of nonionic emulsifiers and an oxygen-loaded fluorocarbon or fluorocarbon mixture, the fluorocarbon content being in the range from 0.05 to 100 % by weight/volume. They are prepared by emulsifiying the corresponding components and incorporating the resulting emulsion in known carriers for, for example, ointments, creams, lotions, waters, alcoholic extracts, pastes, powders, gels, tinctures or masks.

Description: Preparations containing a fluorocarbon emulsion and usable as cosmetics or dermatics The invention relates to cosmetic and dermatolo- gical preparations which are efficient in improving the oxygen supply to the skin. To improve supply of oxygen to the skin, it has already been proposed to use peroxides, such as hydrogen peroxide, in order to stimulate the cell metabolism of the skin via the nascent oxygen formed. However, the considerable side effects, such as skin irritations, have prevented their use. DE-A-2,534,315 claims- an 0 2 -containing cosmetological formulation composed of an 0 2 -saturated gaseous fluorocarbon and a surfactant in aqueous phase in an aerosol container. Borgarello (EP-A-296,661) has developed an isotropic single-phase system for the cosmetic sector in which halogenated compounds are supposed to act as oxygen carriers. A typical composition consists of 34% of a mixture of perchloro-1-butyltetrahydrofuranandpolyfluoro-l-propyl- tetrahydrofuran, 7% of isopropanol, 49% of water and 10% of emulsifier. The emulsifiers used are highly surface- active fluorine surfactants, for example of the perfluoroalkanesulfonamide type, which are known to be extremely toxic on i.p. application in mice (LD50 0.1 to 0.2 g/kg) and also act as an irritant on the skin. Further possible solutions relate to the use of a haemolymph extract from crustaceans or of an extract of proteins and proteids from bovine spleen. Human haemoglobin or, more recently, haemoglobin prepared by biotechnology has hitherto not been available in a form utilizable for topical purposes. Furthermore, it is known that PO/EO block polymers having EO contents of up to 50% have relatively good solubility for gaseous oxygen. In contrast, block polymers having EO contents of 60 to 80% are solid products exhibiting low solubility for oxygen. However, so far no convincing and physically detectable toning and reviving of the skin surface could be achieved by means of the preparations and methods mentioned. The object of the invention is to improve the oxygen supply to the skin by means of a specific prepara¬ tion based on a suitable emulsion of fluorocarbons in such a manner that a detectable effect is achieved. According to the invention, the preparation consists of an aqueous emulsion having a nonionic surfac¬ tant content of 1 to 8% by weight as the emulsifier and an oxygen-loaded fluorocarbon or fluorocarbon mixture content, the fluorocarbon content being in the range from 0.02 to 100% w/v (w/v = weight/volume) in a carrier suitable for the application. The preparation according to the invention can be present, depending on the specific method of application, in solid, liquid or semi-liquid form, for example as powder, lotion, shampoo, cream or gel paste. The carriers suitable for each of these forms are known to one skilled in the art. The essential feature of the invention is the presence of the fluorocarbon emulsion in the prepara¬ tions, which ensures efficient toning of the skin. A multiplicity of fluorocarbons can be used, for example aliphatic straight-chain and branched fluoro- alkanes, mono- or bicyclic and unsubstituted or fluoro- alkyl-substituted fluorocycloalkanes, perfluorinated aliphatic or bicyclic amines, bis(perfluoroalkyl)ethenes, perfluoropolyethers or mixtures thereof. Particularly preferred fluorocarbons are perfluorodecaline, F-butyl- tetrahydrofuran, per luorotributylamine, perfluorooctyl bromide, bis(fluorobutyl)ethene orbis(fluorohexyl)ethene or C 6 -C 9 -perfluoroalkane. The fluorocarbon content in the emulsion is in the range from 20 to 100% by weight/volume, preferably in the range from 40 to 100% by weight/volume. A parti¬ cularly preferred range is that from 70 to 100% by weight/volume. The term "fluorocarbons" used here is understood to mean perfluorinated or highly fluorinated carbon compounds or mixtures capable of transporting gases, such as 0 2 and C0 2 . Highly fluorinated hydrocarbon compounds for the purposes of this invention are those in which most hydrogen atoms have been replaced by fluorine atoms. In most cases, this is achieved if about up to 90% of the hydrogen atoms have been replaced by fluorine atoms. Preferred fluorocarbons for the purposes of the present invention are those in which at least 95% of the hydrogen atom have been replaced, 98% being more preferred and 100% being most preferred. Suitable emulsifiers are nonionic surfactants, such as emulsifiers of the EO/PO block polymer type and/or ethoxylated sorbitan fatty acid esters, fluorina¬ ted nonionic surfactants according to DD-WP131,555 or perfluorinated iminobis(polyoxyalkylene) according to DD- P265,398 Al. These fluorocarbon emulsions can be prepared by DD-WP222,494 Al or another known method ("Tenside Surfactants Detergents", 25 (1989), 5, p. 284). The auxiliary emulsifiers used include alkali metal salts of long-chain fatty acids and phospholipids. The advantage of the preparations according to the invention containing a fluorocarbon emulsion when used as cosmetics or dermatics is that an additional oxygen supply imparted by the fluorocarbon promotes circulation and thus the metabolic processes in the epidermal layer and activates the general state of transpiration. The increased cell respiration strengthens the natural skin defence potential and promotes elimination of skin toxins. In contrast to the known preparations mentioned at the beginning, the preparations according to the invention demonstrate that owing to their extraordinarily high dissolving power for oxygen, the chemically inert fluorocarbons are capable of supplying the skin advan¬ tageously with oxygen in topical application. The use as a cosmetic is not limited to parts of the human face but applies to all epidermal regions of the body, including cellulitis-affected fat tissue with a poor supply and the region of the scalp. Topical application of cosmetics or dermatics containing a fluorocarbon emulsion was previously unknown. Fluorocarbons themselves are chemically and biologically inert organic liquids having a high dissolving power for oxygen. Owing to these characteristics, they have been proposed as gas carriers in blood substitute emulsions and have also been used in humans (K.C. Lowe: "Blood substitutes", Ellis-Horwood, Chichester, GB, 1988). Depending on the intended specific purpose, the fluorocarbons can be selected in accordance with 0 2 solubility, partial vapour pressure and lipid solubility. The critical solubility temperature (CST) of the fluoro¬ carbons in n-hexane correlates with their solubility in lipids, for example cell membranes, and is thus a measure of the rate of release through the skin. Thus, for example, perfluorodecaline and perfluorooctyl bromide which have small CST values are released fairly rapidly, while, on the other hand, F-tributylamine which has a high CST value of 59°C also exhibit a long half life of release. It has been found that fluorocarbons behave ideally upon mixing, and the CST values of such mixtures show a linear relationship with composition. By mixing various fluorocarbons, it is thus possible to establish defined CST values which often cannot be achieved by individual compounds. This finding makes it possible to use fluorocarbon mixtures selectively in order to positively affect the rate of penetration of the skin and their residence time. Incorporation of the fluorocarbon emulsion as active component in ointments, creams, lotions and other aqueous or alcoholic cosmetic formulations is carried out as a function of the intended purpose, it being possible for the fluorocarbon content and thus the 0 2 availability to be varied within wide limits. Before incorporation in any cosmetic systems, such as, for example, gels, pastes, powders, ointments, creams, lotions and waters or alcoholic extracts, the emulsion can be partially loaded or saturated with gaseous oxygen. Saturation with atmos¬ pheric oxygen already ensures a higher oxygen capacity than any comparable known systems by virtue of the equilibrium which is usually established in accordance with Henry's law. According to the invention, the fluorocarbon emulsion content in the cosmetic or dermatological preparations can be in the range from 0.05 to 80% by weight, preferably in the range from 0.05 to 60% by weight, and in particular in the range from 1 to 50% by weight. The invention will now be illustrated in more detail by way of example. Incorporation of the emulsions prepared by DD-WP 494 Al or another known method takes place without difficulties as shown in Example 1. Examples I to III below describe the preparation of fluorocarbon emulsions, which are then used in the preparations of Examples 1 to 17. Exemplary embodiment I 40% of a mixture, 2/3 of which are fluorocarbons, i.e. a mixture of 20% of tetrafluoroethylene and 80% of perfluorotripropylamine, whose boiling range is between 140 and 180°C, and 1/3 of which is the emulsifier polyoxyethylene/propylene copolymer of molecular weight 8000 to 9000, is added to 60% of distilled water with flushing of pure oxygen (0.2 to 0.5 bar), and the mixture is emulsified at an optimum temperature of 7 to 15°C. This can be effected by using any homogenizer having a minimum rotational speed of 10,000 rpm. To sterilize the oxygen-loaded emulsion, 5 to 10% of ethanol or suitable preservatives are added. The desired particle size depends on the homo- genization time. In this example, it is 15 min., resulting in a particle size of 300 to 500 ran. Exemplary embodiment II 25% of a perfluoroalkane mixture in the boiling range between 100 and 140°C, consisting of equal amounts of tetrafluoroethylene and perfluorotripropylamine, are slowly mixed with 8.4% of sorbitan fatty acid ester at a temperature of 5 to 20°C with flushing with pure oxygen (0.2 to 0.5 bar). (The percentages given are based on the content of the finished emulsion.) The remaining 66.6% consists of distilled water, which is added to the perfluoroalkane/sorbitan fatty acid ester mixture by applying high mechanical shearing forces (12,000 to 15,000 rpm) . This gives an oxygen-loaded emulsion, which, after a homogenization time of 20 minutes, has a particle size of 200 to 400 nm. Exemplary embodiment III 23% of a perfluoroalkane mixture in the boiling range 170 to 180°C, consisting of 40% of tetrafluoro- ethylene and 60% of perfluorotripropylamine, and 3% of propylene glycol, molecular weight 2000 to 5000 are premixed with flushing with pure oxygen (0.2 to 0.5 bar) . (The percentages given are based on the content of the finished emulsion.) The remaining 74% of distilled water are dis¬ tributed therein by means of an ultrasound disintegrator (syntrode diameter 20 mm, frequency 50, 40 Hz). Within 2 to 5 minutes, a homogeneous, oxygen-enriched emulsion whose particle size is between 50 and 200 nm, is obtained. The temperature must be between 10 and 25°C. Example 1 Cream for day and night Phase A Sorbitan sesquioleate 6.5% Cetyl alcohol, stearyl alcohol (about 50:50 mixture) 4.0% Isooctyl stearate 3.0% Phase B Propylene glycol 2.1% Allantoin 0.5% Aloe Vera 2.0% Benzoic acid 0.4% Water qs Phase C Perfume oil 1.0% Fluorocarbon emulsion according to Example I 25.0% Preparation Phase A is heated to 65°C with stirring. Phase B is also heated to 65°C and added to Phase A as soon as temperature stability is reached. The homogenization time is 10 minutes. This is followed by the cooling phase. As soon as the temperature of <35°C is reached, the fluoro¬ carbon emulsion and the perfume oil (Phase C) are added with very slow stirring. The preparation is analogous to Example 1< The preparation is analogous to Example 1, The preparation is analogous to Example 1, Preparation: The fluorocarbon emulsion is admixed to the gel at room temperature with slow stirring. Example 6 Sun preparation Emulsifier system consisting of: Liquid paraffin, polyglycerol ester, stabilizers, isopropyl palmitate, bees wax in approximately equal amounts Glycerol MgS0 4 .7H a 0 Vitamin E Aloe Vera Preservative Perfume Fluorocarbon emulsion according to Example II Water The preparation is analogous to Example 1. Example 7 Shower gel Sodium lauryl ether sulphate 37.0% Magnesium lauryl ether sulphate 10.0% Pearl lustre concentrate 3.0% Citric acid 0.5% Fluorocarbon emulsion according to Example II 2.5% Perfume 1.0% Water qs Preparation: The fluorocarbon emulsion is slowly added to the finished shower bath and stirred therein until a homo¬ geneous mixture is obtained'. The preparation is analogous to Example 7 Example 9 Hair conditioner The preparation is analogous to Example 1, Example 10 Roll-on deodorant with a skin-care action Phase A Emulsifier system consisting of: Liquid paraffin, isopropyl palmitate, phosphoric ester in approximately equal amounts 18.0% Phase B Glycerol 3.0% 96 per cent strength ethanol 25.0% Benzoic acid 0.3% Perfume 1.5% Water qs Phase C Fluorocarbon emulsion according to Example II 3.5% Preparation First, Phase A is introduced into the mixer at room temperature. Phase B is then added in portions with rapid stirring, and the mixture is dispersed until homogeneity is reached. Phase C is slowly stirred in. Example 11 Aftershave balm The preparation is analogous to Example 1. Example 12 Foundation, liquid Emulsifier system consisting of: Glyceryl stearate, CH 3 (CH 2 ) 14 CH 2 (OCH 2 CH 2 ) 12 0H, CH 3 (CH 2 ) 14 CH 2 (OCH 2 ) 20 OH, cetyl alcohol/stearyl alcohol (about 50:50 mixture), cetyl palmitate in approximately equal amounts 8.5% The preparation is analogous to Example 1, Example 13 Translucent make-up powder, compact powder Binder emulsion as process promotor Cetyl alcohol/stearyl alcohol (about 50:50 mixture) 3.5% Propylene glycol 4.0% Fluorocarbon emulsion according to Example III 1.5% Water qs The preparation of the binder is analogous to Example 1. Example 14 Eye make-up containing sunscreen factor Polyaerylie acid (mol. weight 4 million) 0.5% TEA 0.5% Sorbitol 4.0% Cetyl alcohol/stearyl alcohol (about 50:50 mixture) 3.5% Paraffin oil 2.0% Propylene glycol 1.5% Fluorocarbon emulsion according to Example III 0.5% Colour combination consisting of: 4.5% White colorant 2.0% Brown colorant 0.5% Black colorant 0.3% Red colorant 1.7% Deionized water qs The preparation is analogous to Example 1. Example 15 Blusher, compacted Talc qs Silk protein 5.0% Pearl lustre pigment 10.0% Magnesium stearate 5.0% Perfume 0.5% Binder emulsion 7.0% Binder emulsion as process promotor. Cetyl alcohol/stearyl alcohol (about 50:50 mixture) Propylene glycol Fluorocarbon emulsion according to Example III Deionized water The preparation of the binder is analogous to Example 1. Example 16 Self-tanning agent The preparation is analogous to Example 1. Preparation: The fluorocarbon emulsion is admixed to the gel at room temperature with slow stirring.

Claims: Patent claims 1. Carrier-based preparation containing a fluoro¬ carbon emulsion and usable as cosmetic/dermatic, characterized in that it contains an aqueous emulsion comprising 1 to 8% by weight of a nonionic surfactant as the emulsifier and an oxygen-loaded fluorocarbon or fluorocarbon mixture, the fluorocarbon content being in the range from 0.02 to 100% w/v (weight/volume) . 2. Preparation according to Claim 1, characterized in that the fluorocarbon content is in the range from 20 to 100% w/v, preferably in the range from 40 to 100% w/v, in particular in the range from 70 to 100% w/v. 3. Preparation according to Claim 1 and 2, charac- terized in that it contains the oxygen-loaded emulsion of the fluorocarbon(s) in an amount of 0.05 to 80% by weight, preferably in an amount of 0.05 to 60% by weight, and in particular in an amount of 1 to 50% by weight. 4. Preparation according to Claim 1 to 3, charac- terized in that the fluorocarbons are selected from the group selected from aliphatic straight-chain and branched fluoroalkanes, mono- or bicyclic, unsubstituted or fluoroalkyl-substituted fluorocycloalkanes, perfluorina¬ ted aliphatic or bicyclic amines, bis(perfluoroalkyl)- ethenes, perfluoropolyethers or mixtures thereof. 5. Preparation according to Claim 4, characterized in that the fluorocarbons are selected from the group consisting of perfluorodecaline, F-butyltetrahydrofuran, perfluorotributylamine, perfluorooctyl bromide, bis- (fluorobutyl)ethene or C 6 -C 9 -perfluoroalkanes. 6. Preparation according to one of Claims 1 to 5, characterized in that it contains, as emulsifier, per- fluorinated iminobis(polyoxyalkylenes) , polyoxyethylene/ polyoxypropylene copolymers, ethoxylated sorbitan fatty acid esters, nonionic ethoxylated fluorine surfactants and/or ethoxylated polypropylene glycols. 7. Use of a preparation according to Claims 1 to 6 as cosmetic/dermatic for controlling the oxygen supply to the skin.

Inventors: ROEDING JOACHIM, STANZL KLAUS, ZASTROW LEONHARD, ROEDING, JOACHIM, STANZL, KLAUS, ZASTROW, LEONHARD
Applicants: LANCASTER GROUP AG, ROEDING JOACHIM, STANZL KLAUS, ZASTROW LEONHARD, ROEDING, JOACHIM, STANZL, KLAUS, ZASTROW, LEONHARD
Application year: 1993
Main classification: A61K7
IPC codes: A61K8, A61K9, A61Q1, A61Q5, A61Q15, A61Q17, A61Q19